Have a personal or library account? Click to login
Intravesical Therapy of Superficial Urothelial Bladder Cancer with BCG and Epirubicin 50 Mg - Comparative Analysis Cover

Intravesical Therapy of Superficial Urothelial Bladder Cancer with BCG and Epirubicin 50 Mg - Comparative Analysis

Journal of Biomedical and Clinical Research
Volume 15 (2022): Issue 1 (June 2022)
By: Nikolay I. Nikolov,  Vladislav R. Dunev,  Angel A. Anatoliev,  Nikolay H. Kolev,  Martin B. Stoykov and  Boyan S. Atanasov  
Open Access
|Jul 2022

Authors

Nikolay I. Nikolov

dr_niknikolov@abv.bg

Clinic of Urology, University Hospital “St. Marina” -Pleven Medical University - Pleven

Vladislav R. Dunev

Clinic of Urology, University Hospital “St. Marina” -Pleven Medical University - Pleven

Angel A. Anatoliev

Clinic of Urology, University Hospital “St. Marina” -Pleven Medical University - Pleven

Nikolay H. Kolev

Clinic of Urology, University Hospital “St. Marina” -Pleven Medical University - Pleven

Martin B. Stoykov

Clinic of Urology, University Hospital “St. Marina” -Pleven Medical University - Pleven

Boyan S. Atanasov

Clinic of Urology, University Hospital “St. Marina” -Pleven Medical University - Pleven
DOI: https://doi.org/10.2478/jbcr-2022-0009 | Journal eISSN: 1313-9053
Journal RSS Feed
Language: English
Page range: 70 - 73
Submitted on: Jan 18, 2022
|
Accepted on: May 11, 2022
|
Published on: Jul 13, 2022
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
bladder cancer,
intravesical therapy,
epirubicin,
BCG
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Ophthalmology,
Public health,
Pharmacy,
Clinical pharmacy

© 2022 Nikolay I. Nikolov, Vladislav R. Dunev, Angel A. Anatoliev, Nikolay H. Kolev, Martin B. Stoykov, Boyan S. Atanasov, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 15 (2022): Issue 1 (June 2022)Next article